What is the dosage and administration guideline for Tramadol in managing moderate to severe pain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nefopam

I cannot provide dosing and administration guidelines for Nefopam based on the evidence provided, as the available research does not support its use for moderate to severe pain management.

Evidence Assessment

Nefopam lacks demonstrated efficacy for moderate to severe cancer pain. A randomized controlled trial found that nefopam 60 mg/24 hours (20 mg every 8 hours) did not provide statistically significant pain reduction compared to placebo in patients with moderate to severe cancer pain 1. While there was a non-significant trend toward reduced morphine consumption (25.5 mg vs 37 mg over 48 hours), this difference was not clinically meaningful (p=0.499) 1.

Clinical Context

The question appears to conflate Nefopam with Tramadol. If you are seeking guidance on Tramadol for moderate to severe pain:

Tramadol Dosing for Moderate Pain

For mild to moderate pain, tramadol should be given in combination with non-opioid analgesics such as paracetamol or NSAIDs 2.

  • Starting dose: 50-100 mg every 4-6 hours orally 3, 4
  • Maximum daily dose: 400 mg/day 5, 4, 6
  • Modified-release formulations: 100-200 mg every 12 hours 2

Critical Limitations of Tramadol

Tramadol is NOT recommended as first-line for moderate to severe cancer pain. The ESMO guidelines explicitly state that oral morphine is the opioid of first choice for moderate to severe cancer pain 2. Evidence shows tramadol produces significantly higher rates of side effects (nausea, vomiting, vertigo, anorexia, asthenia) compared to other opioids without superior analgesic efficacy 2.

The WHO Step II ladder (weak opioids including tramadol) has a time-limited effectiveness of only 30-40 days for most patients 2. Low-dose strong opioids (morphine) should be considered as an alternative to tramadol 2.

Special Populations Requiring Dose Adjustment

  • Elderly patients (≥75 years): Start 25-50 mg every 8-12 hours 5
  • Hepatic or renal impairment: Maximum 50 mg every 12 hours 5
  • Stroke patients: Avoid due to seizure risk, cognitive impairment, and serotonin toxicity concerns 5

Contraindications and Precautions

  • Do not combine with SSRIs or MAO inhibitors due to serotonin syndrome risk 5, 4
  • Screen for seizure history before initiating, as tramadol lowers seizure threshold 5
  • Monitor cognitive function especially in elderly patients 5

Bottom Line

If treating moderate to severe pain, use oral morphine as first-line, not tramadol or nefopam 2. Nefopam at studied doses lacks efficacy 1, and tramadol has significant limitations with higher side effect burden and limited duration of effectiveness 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tramadol: a new centrally acting analgesic.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997

Research

[Pharmacology of tramadol].

Drugs, 1997

Guideline

Tramadol in Stroke Patients: Safety and Efficacy Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical pharmacology of tramadol.

Clinical pharmacokinetics, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.